Charlotte M. Pretzsch

Dr Pretzsch completed a BSc in Neuroscience in Germany and in the United States in 2014, investigating the impact of Oxytocin on the neural circuitry supporting social function in autism. She obtained an MSc in Neuroscience in the UK in 2015, examining resting state brain activity in 22q11.2 Deletion Syndrome (DiGeorge Syndrome).

Following this, she was awarded a PhD in Neuroscience at King’s College London in 2019. Funded by Autistica UK and the NIHR/Biomedical Research Centre, her studies focused on the impact of non-psychoactive cannabinoids on measures of excitation and inhibition (including magnetic resonance spectroscopy and resting state functional magnetic resonance imaging) in autism. For her work, she received the IoPPN Academic Psychiatry Emerging Career Researcher Prize in 2019.

Currently, she is a postdoctoral research associate working in EU-AIMS, an international autism research consortium. Her work focuses on examining the neurobiological (neuroanatomical and genetic) associates of clinical outcome in autism.

Research Interests

• Autism
• Atypical and typical brain development
• Neuroanatomy across the lifespan
• Biomarker discovery
• Pharmacochallenge studies using brain imaging